Indicating a driving role of ALP malfunction – and possibly also of aging – in the pathogenesis of Parkinson’s disease, GBA1 mutation carriers show defects in sphingolipid metabolism and α-synuclein accumulation16,17. This evidence concerns the gene GBA1 and Parkinson disease.